These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10494723)

  • 1. Exfoliative dermatitis after long-term methotrexate treatment of severe psoriasis.
    Peters T; Theile-Ochel S; Chemnitz J; Söhngen D; Hunzelmann N; Scharffetter-Kochanek K
    Acta Derm Venereol; 1999 Sep; 79(5):391-2. PubMed ID: 10494723
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate-Induced Pneumonitis in a Patient With Psoriatic Arthritis and Erythroderma.
    Liu ZH; Shen H
    J Clin Rheumatol; 2021 Oct; 27(7):e260-e261. PubMed ID: 32398511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Body-weight changes in psoriatic patients on systemic treatment].
    Forien M; Mahé E; Sin C; Marchal A; Sigal ML
    Ann Dermatol Venereol; 2012 Oct; 139(10):649-51. PubMed ID: 23122380
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of psoriasis by methotrexate in the era of biotherapies: a study in 21 Tunisian patients].
    Khaled A; Ben Hamida M; Zeglaoui F; Kharfi M; Ezzine N; Fazaa B
    Therapie; 2012; 67(1):49-52. PubMed ID: 22487502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
    Hassan W
    Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
    [No Abstract]   [Full Text] [Related]  

  • 6. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 7. Erosion of psoriatic plaques: an early sign of methotrexate toxicity.
    Pearce HP; Wilson BB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 2):835-8. PubMed ID: 8912599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
    Heikkilä H; Ranki A; Cajanus S; Karvonen SL
    Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
    [No Abstract]   [Full Text] [Related]  

  • 10. [News on psoriasis from the 2010 Dermatology Days in Paris].
    Boulinguez S
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H1-5. PubMed ID: 21703458
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated molluscum contagiosum in a patient on methotrexate therapy for psoriasis.
    Bansal S; Relhan V; Roy E; Garg VK; Khurana N
    Indian J Dermatol Venereol Leprol; 2014; 80(2):179-80. PubMed ID: 24685870
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriasis with minute divided oral doses of methotrexate.
    Spiro JM; Demis DJ
    Arch Dermatol; 1969 Apr; 99(4):459-64. PubMed ID: 4238827
    [No Abstract]   [Full Text] [Related]  

  • 14. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate.
    Homsi S; Alexandrescu DT; Milojkovic N; Abouzgheib W; Bachour K; Homsi Y; Dasanu CA
    Dermatol Online J; 2010 May; 16(5):1. PubMed ID: 20492818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.
    Mrowietz U; Riedl E; Winkler S; Xu W; Patel H; Agada N; Lebwohl MG
    J Am Acad Dermatol; 2020 Nov; 83(5):1436-1439. PubMed ID: 32526319
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis.
    Trídico LA; Antonio JR; Mathias CE; Pozetti EMO
    An Bras Dermatol; 2017; 92(5):743-745. PubMed ID: 29166526
    [No Abstract]   [Full Text] [Related]  

  • 18. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis.
    Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA
    Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
    Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
    Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.